Antibiotice Iasi Seeks Shareholder Approval For Up To RON250M Non-Recourse Factoring Facility From Banca Transilvania

today, 16:28 By Ecaterina Craciun

Pharmaceutical manufacturer Antibiotice Iasi (stock symbol: ATB), controlled by the Ministry of Health, has convened its shareholders for December 17 to approve a non-recourse factoring facility of up to RON250 million (EUR47 million) from lender Banca Transilvania.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Please contact us at 0040 747 825 322 or at camelia.botea@m.ro

LOGIN / Lost password?

 
Keywords:
Antibiotice Iasi
, Shareholders
, Non-Recourse Factoring Facility
, Banca Transilvania